CAS RN: 1046153-20-1
2-Oxa-6-azaspiro[3.5]nonane
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250425
250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
Pack sizes on record: 0.1g, 1g, 0.25g
Available purity: >95%
Inventory rows with stock: 2
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1046153-20-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
>95%
1
In Stock
Beijing
Inquiry
1g
>95%
1
In Stock
Shanghai
Inquiry
0.25g
>95%
0
Out of Stock
Beijing
Inquiry
1046153-20-1 / 2-oxa-8-azaspiro[3.5]nonane
2-Oxa-6-azaspiro[3.5]nonane | DTXSID40679855 | 2-Oxa-6-azaspiro(3.5)nonane
Standard CAS: 1046153-20-1
Multi CAS: Yes
Basic Information
copy
CAS
1046153-20-1 copy
Multi CAS
Yes copy
Molecular Formula
C7H13NO copy
Molecular Weight
127.180000 copy
Exact Mass
127.099714 copy
SMILES
C1CC2(CNC1)COC2 copy
InChI
InChI=1S/C7H13NO/c1-2-7(4-8-3-1)5-9-6-7/h8H,1-6H2 copy
InChIKey
SDESQEIYRGXXPA-UHFFFAOYSA-N copy
Synonyms
2-Oxa-6-azaspiro[3.5]nonane
DTXSID40679855
2-Oxa-6-azaspiro(3.5)nonane
RefChem:264543
DTXCID00630604 copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Fraction Csp3
1 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
35.36 copy
TPSA
21.26 copy
LogP / Solubility
WLOGP
0.39 copy
MLOGP
0.33 copy
Consensus LogP
0.24 copy
Log S (ESOL)
-0.87 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-0.88 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-0.81 copy
Class (SILICOS-IT)
Very soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.22 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 38 of 39 companies (only 2.6% companies provided GHS information). For more detailed information, please visit ECHA C&L website. copy